SOLICITATION NOTICE
66 -- Ocentra Prostate-Hardware and Software
- Notice Date
- 6/1/2014
- Notice Type
- Presolicitation
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 9609 Medical Center Drive, Room 1E128, Rockville, Maryland, 20852, United States
- ZIP Code
- 20852
- Solicitation Number
- N02RC462540-83
- Archive Date
- 7/2/2014
- Point of Contact
- Gwennifer K. Epps, Phone: 240-276-5445, Terry Galloway, Phone: 240-276-5384
- E-Mail Address
-
eppsg@mail.nih.gov, gallowaytl@mail.nih.gov
(eppsg@mail.nih.gov, gallowaytl@mail.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- The National Cancer Institute (NCI), Center for Cancer Research (CCR), Radiation Oncology Branch (ROB), plans to procure a Elekta Oncentra Prostate upgrade package of hardware and software from Elekta, Incorporated (Nucletron), 400 Perimeter Center, Terrace Suite 50, Atlanta, GA, 30346 USA. This process will be processed in accordance with simplified acquisitions procedures as stated in FAR Part 13 13.106-1(b)(1) and is exempt for the requirements of FAR Part 6. The North American Industry Classification System code is 334516, and the business size standard is 500 employees. Only one award will be made as a result of this solicitation. This will be awarded as a firm fixed price type contract. It has been determined there are no opportunities to acquire green products or services for this procurement. The Radiation Oncology Branch (ROB) exists to plan and conduct pre-clinical and clinical research on the biologic and therapeutic effects of radiation administrated alone or in combination with other modalities of treatment; to develop novel technology and imaging based approaches for radiation oncology; to investigate the natural history of disease to understand and evaluate means of diagnostic assessment for the purpose of optimizing treatment selections; and to provide radiation therapy as well as general oncology consultations for patients admitted to other Clinical Research Center (CRC) clinical services, in a collaborative approach. Recently, NCI 's ROB has decided to revisit prostate implants utilizing a 3-dimensional ultrasound imaging technique. The importance of this technique is that it incorporated the existing Government owned equipment and simply involves incorporating attachments to produce a real-time 3-dimensional of a patient's anatomy in the prostate region. The Oncentra Prostate package from Elekta Inc. includes a new stepper adapter and probe cradle which fits the existing stepper and probe, yet is compatible with the new EndoCavity Rotational Mover (ECRM). The computer controlled ECRM is used to reliably and accurately rotate the ultrasound probe. A Stepper Encoder provides rotational coordinate information for each sagittal probe image which is used to generate a 3-dimentikonal image of the local autonomy. In addition, Oncentra Prostate treatment planning software incorporates the 3D ultrasound volume, allows for the fusion of it to a CT or MR image set and for the user to determine the optimum implant geometry in real-time. Treatment planning (including inverse planning), optimization and implant evaluation can be performed quickly, saving time for the overall procedure. The acquisition is for the Oncentra Prostate package of hardware and software that will extend the capabilities of the existing, Government owned Nucletron Prostate Stepper and template and the B-K Pro Focus-G ultrasound unit with attached MFI Trans-Rectal Bi-Plane Transducer array to provide a real-time, 3D ultrasound image permitting the visualization of each needle path as it is inserted and providing subsequent needle trajectories consistent with an optimal implant array, generating treatment plan dose distributions, dose optimization and implant evaluation and transferring the resulting catheter dwell positions via network to the existing Nucletron Treatment Control System (TCS) so that the treatment can be accurately delivered by the existing Nucletron MicroSelectron v.3 high dose-rate (HDR) remote after loading unit. A sole source is intended for this order, based on the fact that Elekta Incorporated acquired Nucletron in 2011 and continues to solely market and support Nucletron's brachytherapy products. Elekta has developed the adapters, controllers and interfaces to enable the B-K trans-rectal transducer array to collect 3-dimensional sectored data and reconstruct them into a volumetric image for image guided needle placement, treatment planning and transfer of treatment critical information to the treatment delivery system. This is not a solicitation for competitive quotations. However, if any interested party especially small business, believes they can meet the above requirement, they may submit a statement of capabilities. All information furnished must be in writing and must contain sufficient detail to allow the NCI to determine if it can meet the above unique specifications described herein. An original and one copy of the capability statement must be received in the NCI Office of Acquisitions on or before 11:00 AM EST on, June 17, 2014. No electronic capability statements will be accepted (i.e. email or fax); an original and one copy must be sent to the NCI Office of Acquisitions at the address stated above. All questions must be in writing and can be faxed (240) 276-5401 or emailed to Gwennifer Epps, Contracting Officer at eppsg@mail.nih.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. In order to receive an award, contractors must have valid registration and certification in the Central Contractor Registration (CCR) and the Online Representations and Certifications Applications (ORCA), through sam.gov. No collect calls will be accepted. Please reference solicitation number N02RC42540-83 on all correspondence.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/RCB/N02RC462540-83/listing.html)
- Place of Performance
- Address: Building 10, NCI, Bethesda, Maryland, 20892, United States
- Zip Code: 20892
- Zip Code: 20892
- Record
- SN03382034-W 20140603/140601233629-0cd3a700c6b1670fa15a67152465cb5e (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |